Multiparametric 18F-FDG PET/MRI of the Breast: Are There Differences in Imaging Biomarkers of Contralateral Healthy Tissue Between Patients With and Without Breast Cancer?

Conclusion: Differences in multiparametric 18F-FDG PET/MRI biomarkers, obtained from contralateral tumor-free breast tissue, exist between patients with benign and patients with malignant breast tumors. Contralateral BPE, BPU, and FGT are decreased in breast cancer patients and may potentially serve as imaging biomarkers for the presence of malignancy.

Source: Journal of Nuclear Medicine - January 1, 2020 Category: Nuclear Medicine Authors: Leithner, D., Helbich, T. H., Bernard-Davila, B., Marino, M. A., Avendano, D., Martinez, D. F., Jochelson, M. S., Kapetas, P., Baltzer, P. A. T., Haug, A., Hacker, M., Tanyildizi, Y., Morris, E. A., Pinker, K. Tags: Clinical Source Type: research